Abiomed Inc.

This study tests a small heart pump called Impella ECP in 100 adults undergoing high-risk angioplasty (a procedure to open blocked heart arteries). The pump is inserted temporarily to help the heart keep pumping blood during the procedure. The goal is to see if the device is safe…

This study tests if using a temporary heart pump (Impella CP) for 30 minutes before opening a blocked artery can reduce heart damage in people having a major heart attack. About 527 adults with a first-time anterior heart attack are taking part. The goal is to see if this approac…

This study looks at how safe and effective the Impella 5.5 heart pump is for people with weak hearts who need high-risk heart surgery. About 123 patients with severe heart failure will take part. The goal is to see if the pump helps prevent serious problems like death, stroke, or…

This study tests a temporary heart pump called Impella ECP in 856 adults undergoing high-risk angioplasty (a procedure to open blocked heart arteries). The pump helps keep blood flowing during the procedure. Researchers are checking how often serious heart or brain problems occur…

This early study tests a small heart pump called Impella BTR in 10 adults with severe heart failure. The pump is placed inside the body to help the heart pump blood for up to 28 days. The goal is to see if it is safe and can support patients until their heart recovers or they rec…

This study looks at whether using the Impella heart pump during a high-risk procedure to open blocked arteries can help people with weak hearts feel better and live longer compared to standard care. About 1,250 adults with reduced heart function and complex coronary artery diseas…

This study tests whether using the Impella 5.5 heart pump during high-risk heart surgery helps people with severely weakened hearts. About 100 participants will receive the pump to support their heart function during and after surgery. The goal is to see if it reduces death, stro…

This study gathers detailed, real-time information from the Impella heart pump and standard monitors in 125 people with cardiogenic shock. The goal is to better understand how the pump and body work together, not to test a new treatment. Participants are already using the Impella…